Hoberman Kenneth 4
4 · Nuvectis Pharma, Inc. · Filed Apr 5, 2022
Insider Transaction Report
Form 4
Hoberman Kenneth
Director
Transactions
- Award
Stock Options (right to buy)
2022-04-01+15,000→ 15,000 totalExercise: $7.02From: 2023-04-01Exp: 2032-04-01→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The options will vest according to the following schedule: one-third on each of 4/1/2023, 4/1/2024, and 4/1/2025.